of the Royal Society of Edinburgh and in 2014 she was also
appointed Professor of Forensic Science and Director of Research
of the Centre for Anatomy and Human Identification (CAHID),
University of Dundee, one of the world's leading research centres
in forensic science and forensic anthropology. Professor Nic
Daeid completed her PhD at RCSI in bio-inorganic chemistry
under the supervision of Professor Kevin Nolan in 1993. After
her PhD, Professor Nic Daeid was appointed lecturer in Forensic
Science at the Department of Pure and Applied Chemistry at
Strathclyde University, Glasgow, where she established an international reputation in
forensic science research, education and professional development. She was promoted
firstly to Senior Lecturer, then Reader and later Professor in 2011, making her the first
female to earn a personal Chair in the Department of Chemistry in Strathclyde's history.
Professor Nic Daeid is the immediate past chair of the European Network of Forensic
Institutes Fire & Explosion Investigation Working Group representing 63 forensic
science laboratories and also chairs the Interpol organising committee for the forensic
science managers symposium. She acts as consultant for the United Nations Office
on Drugs and Crime (UNODC) and is vice-chair of the scientific advisory board for
the International Criminal Court. She is also vice-chair of the Royal Statistical Society's
section for science and law. In 2015, she won, with Professor Sue Black, a £10m
research grant to establish the Leverhulme Research Centre for Forensic Science at the
University of Dundee.
in the public and private hospital sectors in Malaysia for almost
10 years. He later ventured into the medical insurance industry
as Medical Manager at American International Assurance, one
of the largest medical insurance providers in Malaysia. In 2002,
he was headhunted to lead the Medical Department in the
global research-based biopharmaceutical company, AstraZeneca
Malaysia & Brunei, where he worked for over 12 years. In 2011,
he became Head of Government Affairs, AstraZeneca Malaysia.
His role in the industry is clinical research management and
regulatory, medical and government affairs. He now leads Clinical Research Malaysia
(CRM) as their Chief Executive Officer. CRM is a non-profit Malaysia Ministry of Health-
owned company, which promotes industry-sponsored studies as a one-stop centre.
Mercy Hospital, whilst Dr Cooper has a busy general surgery practice. They both visit
Ireland periodically, and look forward to returning to RCSI in August for their 25th reunion.
(1994) in Singapore, Anisha Pillay (1993) and Ravin Sadhai (1994) in Melbourne; Edwin
Lip (1996) in Perth; Juggy Sidhu (1995) in Hong Kong, plus there was a reunion in Kuala
Lumpur! Next up is a return to Kuala Lumpur for his favourite classmate, Veronica Chelliah's
birthday in May.
(1993) and Raj
is Associate Professor
of Public Health in
Dublin (UCD) and
Deputy Director of
the UCD Institute for
Food and Health. He
was the head of the
Division of the UK Communicable Disease
Surveillance Centre (1994-1996), and the
first Chief Executive of the Irish Food
Safety Authority (1998-2002). He was a
founder member of the management
board, and the second Chairperson, of
the European Food Safety Authority
(2002-2007). He is currently a member of
the Scientific Advisory Committee of the
Chinese National Centre for Food Safety
Risk Assessment. A keen horseman, since
2012 he is Chairperson of Horse Sport
Ireland, the national federation overseeing
equestrian sport in Ireland. He qualified
in veterinary medicine in UCD (1979)
and in human medicine in RCSI (1986).
In addition, he has an MSc in Infectious
Diseases from the University of London
(1992), an MBA from the Michael Smurfit
School of Business, UCD, and a Diploma
in Corporate Governance from the UCD
Centre of Corporate Governance.
(Class of 1981)
is the Senior Physician
at the Liver Center at
Beth Israel Deaconess
Medical Center in
and Professor of
Medicine at Harvard Medical School.
Dr Afdhal graduated from Medicine
in RCSI in 1981 and did his fellowship
training at University College Dublin and
at Boston University School of Medicine.
Dr Afdhal's clinical expertise focuses on
the management of the complications of
liver disease, including cirrhosis and portal
hypertension. He has published more than
250 original manuscripts, reviews and
editorials in journals such as New England
Journal of Medicine, Gastroenterology,
Hepatology, Gut, and Journal of
Hepatology, as well as 40 book chapters
and two books. He is the Editor for the
Journal of Viral Hepatitis. He was the lead
Investigator of the Ion trials which led to
a cure for most patients with Hepatitis C.
His strong belief in research opportunities
have continued with his support of student
research at RCSI along with his wife and
classmate, Clare Tempany-Afdhal.